Breakthrough from Weill Cornell Medicine

Researchers from Weill Cornell Medicine in New York have figured out how to grow pulmonary neuroendocrine cells (PNECs) from human embryonic stem cells.  This gives new insight into two genes that are commonly mutated in small cell lung cancer (SCLC).

The Weill Cornell team was co-led by Nobel Prize winner and former National Cancer Institute director Harold Varmus M.D.

Click here to read full article on Fierce Biotech website

 

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NECA at ENETS 2025: Advancing NET Care on the Global Stage

The Australian Cancer Plan

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.